TherapeuticsMD, Inc. (TXMD) Earnings History
Annual and quarterly earnings data from 1994 to 2024
Loading earnings history...
TXMD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TXMD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 100.0% | -270.3% | -123.9% |
| 2023 | 100.0% | -654.6% | -789.4% |
| 2022 | 98.0% | 1.7% | 160.1% |
| 2021 | 45.5% | -3092.8% | -6700.9% |
| 2020 | 75.4% | -239.8% | -282.9% |
Download Data
Export TXMD earnings history in CSV or JSON format
Free sign-in required to download data
TherapeuticsMD, Inc. (TXMD) Earnings Overview
As of May 8, 2026, TherapeuticsMD, Inc. (TXMD) reported trailing twelve-month net income of $302,000, reflecting +74.3% year-over-year growth. The company earned $0.03 per diluted share over the past four quarters, with a net profit margin of -123.9%.
Looking at the long-term picture, TXMD's historical earnings data spans multiple years. The company achieved its highest annual net income of $112M in fiscal 2022.
TherapeuticsMD, Inc. maintains positive profitability with a gross margin of 100.0%, operating margin of -270.3%, and net margin of -123.9%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including PGNY ($68M net income, 4.5% margin), DARE (-$17M net income, -41430.9% margin), ANIP ($78M net income, 8.9% margin), TXMD has room to improve margins relative to the peer group. Compare TXMD vs PGNY →
TXMD Earnings vs Peers
Earnings metrics vs comparable public companies
TXMD Historical Earnings Data (1994–2024)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$2M | +78.8% | -$5M | $-0.19 | -123.9% | -270.3% |
| 2023 | -$10M | -109.2% | -$9M | $-0.74 | -789.4% | -654.6% |
| 2022 | $112M | +165.0% | $1M | $-10.35 | 160.1% | 1.7% |
| 2021 | -$172M | +6.1% | -$80M | $-25.83 | -6700.9% | -3092.8% |
| 2020 | -$184M | -4.2% | -$156M | $-38.58 | -282.9% | -239.8% |
| 2019 | -$176M | -32.8% | -$151M | $-39.79 | -354.8% | -304.6% |
| 2018 | -$133M | -72.4% | -$130M | $-29.47 | -823.7% | -808.8% |
| 2017 | -$77M | +14.4% | -$78M | $-18.71 | -458.5% | -462.7% |
| 2016 | -$90M | -5.6% | -$90M | $-22.92 | -464.3% | -466.3% |
| 2015 | -$85M | -56.9% | -$85M | $-24.56 | -422.4% | -422.9% |
See TXMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TXMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TXMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTXMD — Frequently Asked Questions
Quick answers to the most common questions about buying TXMD stock.
Is TXMD growing earnings?
TXMD EPS is $0.03, with earnings growth accelerating to +74.3%. This exceeds the 5-year CAGR of N/A. TTM net income reached $302000.00.
What are TXMD's profit margins?
TherapeuticsMD, Inc. net margin is -123.9%, with operating margin at -270.3%. Below-average margins reflect competitive or cost pressures.
How consistent are TXMD's earnings?
TXMD earnings data spans 1994-2024. The accelerating earnings trend is +74.3% YoY. Historical data enables comparison across business cycles.